Top news of the week: 25.01.2023.
Beyond Biotech - the podcast from Labiotech
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around ...
Ellipses Accelerates Cancer Treatment R&D With ‘Unique’ Business Model
<p><strong><span style="color: #111111;">Emerging Company Profile: </span></strong><span style="color: #111111;">The UK biotech is working to expedite its portfolio of acquired drug ...
Weeks After Reverse Merger, Disc Expands Hematologic Pipeline
Disc Medicine announced it had inked an exclusive license agreement with Mabwell Therapeutics for the latter’s portfolio of monoclonal antibodies against the TMPRSS6 protein.
Listen: How blockbusters get made, new vaccines for RSV, and mRNA’s Q score
Where do new drugs come from? Does science need billionaires? And do normal people care about messenger RNA? Find out on the latest episode of "The Readout LOUD" #podcast.
The future of single-cell microfluidics in cell engineering
Single-cell microfluidic-based techniques continue to be a key enabling technology for cell engineering, according to Sphere Fluidics.
India M&As Overtook PE Activity In 2022, Deal Momentum To Continue In 2023
<p>India had a busy deals calendar in 2022, with companies led by Biocon striking large M&A deals while PE activity declined. <em>Scrip</em> pieced together data for infographics on ...
How HALO Slip Proved Costly For CinCor In AstraZeneca Talks
<p>Hindsight is a wonderful thing but the saga of AstraZeneca's acquisition of CinCor is an eye-opener as SEC filings reveal that a $60 per share offer was rejected in September before a ...
Virtual Event: Matthew Cobb
As Gods: A Moral History of the Genetic Age in conversation with KEVIN DAVIES Harvard Book Store, the Harvard University Division of Science, and the Harvard Library welcome …